3 results
Approved WMOCompleted
see protocol summary
Approved WMOCompleted
To assess the safety and tolerability profile of LJN452 and to determine the early hepatic response to different doses of LJN452 in patients with phenotypic non-alcoholic steatohepatitis (NASH). Data from this study will be used to support further…
Approved WMORecruiting
The aim of this study is to collect data to confirm clinical safety and performance of the Amvia pacemaker family to fulfil the regulatory requirements for products that are available on the market. The collected data may also be used to support…